Purdue’s Head Of R&D Has Broad Remit To Bring In New Assets

Newly appointed senior VP-R&D Alan Dunton is charged with curing the firm's dependency on pain products.

Purdue Pharma LP, in the midst of a transformation, has a new senior VP-R&D Alan Dunton, who is charged with taking a company known exclusively for its work in pain into new areas and building out the pipeline.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D